Physician profile
Terry L Fall
NPI 1356337851
$1,772.60
in general payments reported to CMS, 2019-2025
14 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $276 · 2021: $229 · 2022: $285 · 2023: $223 · 2024: $265 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.59 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $473.86 | 2022-2025 | |
| Allergan, INC. | $231.93 | 2019-2022 | |
| Glaukos Corporation | $195.56 | 2021-2024 | Ce-Marked Kxla System |
| Horizon Therapeutics Plc | $184.97 | 2021-2023 | Tepezza |
| Biotissue Holdings INC. | $164.12 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $152.44 | 2019-2020 | |
| Coopervision INC. | $91.19 | 2022 | |
| Sun Pharmaceutical Industries INC. | $68.52 | 2019-2025 | |
| Amgen INC. | $60.51 | 2024-2025 | Tepezza |
| Mallinckrodt Hospital Products INC. | $50.25 | 2021-2024 | Acthar |
| Bausch & Lomb Americas INC. | $34.06 | 2023-2024 | Miebo |
| Sight Sciences, INC. | $24.79 | 2022 | |
| Alcon Vision LLC | $20.80 | 2024 | Rocklatan |
| Aerie Pharmaceuticals, INC. | $19.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Fall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.